Complete and partial responses of the TEMPI syndrome to bortezomib

N Engl J Med. 2012 Aug 23;367(8):778-80. doi: 10.1056/NEJMc1205806.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Erythropoietin / blood
  • Female
  • Humans
  • Male
  • Middle Aged
  • Paraproteinemias / drug therapy*
  • Polycythemia / drug therapy*
  • Pyrazines / therapeutic use*
  • Syndrome
  • Telangiectasis / drug therapy*

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Erythropoietin
  • Bortezomib